PetVivo, makers of Spryng™ with OsteoCushion™ Technology, introduces new Q&A sessions with equine expert Dr. Tracy Turner
June 01 2022 - 1:00PM
PetVivo, the company who makes SpryngTM with OsteoCushionTM
Technology, is proud to work in collaboration with Dr. Tracy
Turner, a recognized expert in equine lameness diagnosis, on new
video Q&A sessions on joint health. Dr. Tuner, with more than
four decades of experience, has seen the full spectrum of lameness
and joint issue management products and when he encountered
SpryngTM with OsteoCushionTM Technology, an intra-articular
injectable veterinary device, he knew he had come across a
potential game-changer.
"I love telling the story of the first stifle I injected with
SpryngTM. The horse was a strong grade three out of five lame with
a beat-up meniscus. I told the owner she was likely at the end of
her career, but that we could try injecting this new product,"
recounts Dr. Turner, owner of Turner Equine Sports Medicine and
Surgery. "When I came back two weeks later, I didn't believe I was
looking at the same horse — she was 100% sound. The only thing I
had done was a SpryngTM injection. I stepped out of the barn that
day knowing I had found a real boon to veterinary medicine."
Available only through licensed veterinarians, SpryngTM with
OsteoCushionTM Technology is an innovative intra-articular
injectable veterinary medical device that is designed to aid in the
management of joint pain from loss of cartilage or tissue-bone
mechanical malfunction caused by joint dysfunction not associated
with infection (e.g., lameness, osteoarthritis, degenerative joint
disease). A single SpryngTM injection provides both immediate
joint protection and helps protect the joint from further injury,
unlike other products that only treat symptoms.
"Anti-inflammatories eliminate the inflammatory process, but
they don't address the consequences of that," says Dr. Turner.
"SpryngTM is a product that needs to be in our toolbox for treating
joint diseases and other arthritic type diseases. I recommend it to
every veterinarian around the country."
Dr. Turner, who has used SpryngTM with OsteoCushionTM
Technology for 10 years and joined the Veterinary Advisory
Board of parent company PetVivo Holdings, Inc. in 2018, recently
released a series of Q&A videos recounting his experience with
and assessment of the SpryngTM product. The full video collection
can be viewed on SpryngHealth.com.
About Dr. Tracy Turner
Dr. Turner is a Diplomate in the American College of Veterinary
Surgeons, American College of Veterinary Sports Medicine and
Rehabilitation, and he is a Fellow of the American Academy of
Thermology. He received his DVM degree from Colorado State
University in 1978, after which he pursued his interest in equine
medicine and surgery. He is board-certified in veterinary surgery
and Equine Sports Medicine and Rehabilitation. Dr. Turner served on
the faculty of the University of Illinois, University of Florida
and the University of Minnesota. He joined Anoka Equine Clinic in
2004, then started his own practice in 2016 dedicated strictly to
Sports Medicine, Lameness, and Surgery.
Dr. Turner consults for the FEI and United States Equestrian
Federation. He has worked at four Pan American Games, two World
Equestrian Games, and the 2020 Tokyo Olympics. Read Dr. Turner's
full biography here: https://www.petvivo.com/team-bios
About Spryng™ with OsteoCushion™ Technology
SpryngTM with OsteoCushionTM Technology is a veterinary
medical device by PetVivo, Inc., a wholly-owned subsidiary of
PetVivo Holdings, Inc. SpryngTM is a veterinarian-administered,
intra-articular injection designed to aid in the management of
lameness issues, joint pain and osteoarthritis from loss of
cartilage or tissue-bone mechanical malfunction caused by joint
dysfunction not associated with infection. SpryngTM is
currently available for use in horses and small animals and is
available for commercial sale. To learn more about SpryngTM
with OsteoCushionTM Technology, please contact info1@petvivo.com or
visit https://www.sprynghealth.com.
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc. (NASDAQ: PETV) is an emerging biomedical
device company currently focused on the manufacturing,
commercialization and licensing of innovative medical devices and
therapeutics for companion animals. The Company's strategy is to
leverage human therapies for the treatment of companion animals in
a capital and time efficient way. A key component of this strategy
is the accelerated timeline to revenues for veterinary medical
devices, which enter the market much earlier than more
stringently-regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for the treatment
of animals and people. A portfolio of nineteen patents protects the
Company's biomaterials, products, production processes and methods
of use. The Company's lead product SpryngTM with OsteoCushionTM
technology.
For more information about PetVivo Holdings, Inc. and our
revolutionary product, SpryngTM with OsteoCushionTM Technology,
please contact info1@petvivo.com or visit https://petvivo.com/.
Press Contact: Mary
Kempspryng@kickmpls.com
###
Related Images
Image 1: Spryng with OsteoCushion Technology QR
Code Hear all the insights from Dr.Tracy Turner in our
Q&A session
This content was issued through the press release distribution
service at Newswire.com.
- Spryng with OsteoCushion Technology QR Code
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Mar 2024 to Apr 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Apr 2023 to Apr 2024